The ALS Better Care Act adds a new Medicare benefit category—'ALS-related services'—covering a defined bundle of multidisciplinary outpatient services for beneficiaries medically determined to have amyotrophic lateral sclerosis. It requires CMS to pay a single supplemental payment to qualified providers for those services beginning January 1, 2027, and bars patient cost-sharing for the payment portion under this new system.
The measure matters because it moves beyond ad hoc billing for disparate services and creates a targeted payment designed to shore up ALS specialty clinics, support telehealth access, and provide explicit incentives for providers engaged in ALS clinical trials. For compliance officers and finance leads, the bill creates new billing codes, a defined qualified‑provider standard (to be regulated), triennial GAO price reviews, and programmatic payments that will affect revenue modeling and operations for ALS centers and CMS alike.
At a Glance
What It Does
Defines 'ALS-related services' (a list of multidisciplinary supports and coordination) and adds them to the Medicare benefit categories. Establishes a single annual payment per visit to a 'qualified provider' for those services, starting January 1, 2027, with indexing and triennial Comptroller General review.
Who It Affects
Medicare beneficiaries diagnosed with ALS, outpatient specialty clinics and providers that deliver ALS care, CMS and Medicare contractors responsible for claims processing, and NIH/NINDS via a directed report on clinical trial staffing and administration.
Why It Matters
It creates a targeted reimbursement pathway intended to stabilize financing for ALS specialty care, expand telehealth use for ALS patients, and incentivize provider participation in clinical trials—changing how ALS outpatient services are paid and monitored under Medicare.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The bill adds a new category of Medicare-covered services specifically for people medically determined to have ALS. Rather than relying solely on separate billing for individual visits and therapies, the statute lists key components—specialized physician or nurse practitioner support, occupational and speech therapies, physical therapy, dietary and respiratory support, registered nursing, and coordination of durable medical equipment—and treats those collectively as 'ALS-related services' when furnished in an outpatient setting.
For payment, CMS must implement a single supplemental payment to a 'qualified provider' for ALS-related services furnished during a visit. The initial base amount is specified ($800 for 2027 and 2028 subject to GAO adjustment), and thereafter the payment is indexed to an 'ALS services market basket' increase set by CMS, with the Comptroller General conducting a triennial review that can recommend a higher payment.
CMS must accept claims tied to an ICD‑10‑CM code for ALS and make the supplemental payment on an assignment-related basis without cost-sharing to the beneficiary.The payment system includes two adjustment pathways: an add-on for qualified providers participating in at least one ALS clinical trial listed on clinicaltrials.gov, and adjustments to account for material new services or technologies incorporated into ALS care that were not paid under the prior year. CMS will determine who counts as a 'qualified provider' through notice-and-comment rulemaking (though other implementation elements may proceed by program instruction).
The bill also requires the NIH/NINDS director to report within 90 days on administrative and staffing challenges for ALS clinical trials and to recommend actions, including potential legislative and funding requests.
The Five Things You Need to Know
Effective date: ALS-related services are covered under Medicare for services furnished on or after January 1, 2027.
Service definition: 'ALS-related services' is a statutorily enumerated bundle—specialized physician or NP support, occupational and speech therapy, physical therapy, dietary and respiratory support, registered nursing, and durable medical equipment coordination—when provided in an outpatient setting to a beneficiary medically determined to have ALS.
Single payment mechanics: CMS must pay a single supplemental payment to a qualified provider per visit (assignment-only, no beneficiary cost-sharing), starting at $800 for 2027 and 2028, then indexed by an ALS services market basket with a triennial GAO review that can recommend higher amounts.
Incentives and adjustments: The payment system must add adjustments for qualified providers participating in at least one clinical trial listed on clinicaltrials.gov and for new medical services or technologies whose costs are significant and were not previously paid.
Provider standards and claims: CMS will require qualified providers to meet regulatory criteria (issued through notice-and-comment rulemaking) and will trigger supplemental payments when claims include an ALS ICD‑10‑CM diagnosis code.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Names the measure the 'ALS Better Care Act.' This is the statutory label and has no programmatic effect but signals the bill’s focus on targeted ALS care financing.
Findings
Congress records policy findings that multidisciplinary ALS clinic services extend life and quality of life, that current Medicare reimbursement is inadequate, that telehealth is important especially for rural and mobility-limited patients, and that clinical trial staffing and funding are constrained. Practically, the findings establish the legislative rationale for treating ALS care as a distinct Medicare concern and for linking payment reforms to telehealth and clinical trials.
Adds 'ALS-related services' to benefit categories (Social Security Act §1861)
Amends section 1861 to add a new subsection defining 'ALS-related services' and 'covered ALS individual' (medical determination of ALS, referencing section 226(h)). The definition is limited to outpatient settings and ties coverage eligibility to a clinical diagnosis, which standardizes when the new benefit applies and anchors it to recognized diagnostic coding.
Payment system and structure (Social Security Act §1834 new subsection aa)
Creates a new payment subsection requiring CMS to implement a single payment to qualified providers for ALS-related services during a visit, with a specified base amount ($800 for 2027), annual indexing via an 'ALS services market basket,' and triennial Comptroller General pricing reviews that can increase the payment. The subsection prescribes claim mechanics (ICD‑10‑CM diagnostic code triggers), prohibits beneficiary cost-sharing for the payment portion, and mandates payment adjustments for trial participation and significant new services or technologies. It also defines 'qualified provider' and requires CMS to adopt regulatory criteria through notice-and-comment rulemaking.
Conforming amendments to claims/payment rules
Modifies section 1833(t) so covered outpatient department services furnished to a covered ALS individual remain payable notwithstanding payments under the new subsection, and adjusts the definition of 'arrangements' in section 1861(w)(1) to reference qualified providers for ALS-related services. These changes clarify how the new payment interacts with existing OPPS payments and third-party arrangements to avoid unintended payment denials.
NIH/NINDS report on ALS clinical trial administration and staffing
Directs the NIH/NINDS director to submit a report within 90 days identifying administrative and staffing challenges for ALS clinical trials, actions NINDS can take, and any legislative or appropriation recommendations. This is an oversight and planning requirement intended to align the payment reforms with trial capacity and workforce issues.
This bill is one of many.
Codify tracks hundreds of bills on Healthcare across all five countries.
Explore Healthcare in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Medicare beneficiaries diagnosed with ALS — Gain explicit coverage for a multidisciplinary set of outpatient ALS supports and no patient cost-sharing for the supplemental payment portion, improving access and reducing out-of-pocket variability.
- ALS specialty clinics and multidisciplinary providers — Receive a predictable supplemental payment per visit designed to improve revenue stability, cover care coordination and multidisciplinary services, and reduce the pressure of inadequate per‑service reimbursement.
- Patients in rural areas and care deserts — The bill’s findings and telehealth emphasis, combined with the outpatient payment structure, make remote management more financially viable for providers, potentially lowering travel burdens and wait times.
- Clinical researchers and trial sites — Providers participating in at least one clinical trial listed on clinicaltrials.gov qualify for a payment adjustment, creating a direct financial incentive to host or maintain trial activity and potentially improving trial capacity.
Who Bears the Cost
- Medicare program/Trust Funds — Expanding coverage and creating a supplemental payment with indexing and trial add-ons will increase Medicare outlays relative to current payment patterns for these services.
- CMS and Medicare administrative contractors — Face new implementation work: creating claims edits and ICD‑10 triggers, administering assignment-only payments, building the ALS services market basket, and conducting oversight to prevent miscoding or inappropriate billing.
- Non‑qualified or small outpatient providers — Providers that do not meet the forthcoming 'qualified provider' regulatory standard may be excluded from receiving supplemental payments and will need to restructure staffing or partnerships to remain financially viable when treating ALS patients.
- Qualified providers (operationally) — While they gain revenue, these providers must comply with regulatory requirements, potentially invest in systems to document multidisciplinary services and clinical trial participation, and bear any incremental staffing or reporting duties.
Key Issues
The Core Tension
The bill tries to guarantee comprehensive, multidisciplinary ALS care through a dedicated supplemental payment and trial incentives, but doing so risks higher Medicare spending and creates sharp implementation choices about which providers qualify and how payments are indexed—forcing policymakers to choose between broad access and tight fiscal and fraud controls.
The bill sets a structured payment but leaves several consequential details to agency rulemaking and administrative implementation. CMS must create an 'ALS services market basket'—a nonstandard index that requires selecting an appropriate item mix and data sources; the choice of components and weights will materially affect future payment growth.
The statute’s triennial Comptroller General report provides an external check, but the GAO’s recommended payment only applies if higher than the market-basket outcome and only every third year, leaving interstitial years reliant on CMS estimates. That design balances responsiveness with administrative predictability but creates lags where actual cost growth outpaces the index.
Defining 'qualified provider' via notice-and-comment rulemaking is sensible for stakeholder input but inserts timing and standards risk: tight eligibility rules could concentrate payments in larger centers, while loose standards raise concerns about upcoding or diffuse billing. The statute attempts to curb beneficiary financial exposure by making the supplemental payment assignment-only and without cost-sharing, but it does not explicitly address other cost-sharing that might attach to separately payable items—CMS’s interpretations and edits will determine the real out-of-pocket effect.
Finally, the clinical trial add-on and adjustment for new technologies aim to promote innovation, yet they create an incentive structure that may favor trial-linked providers and potentially complicate equitable resource distribution across non-trial sites.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.